Literature DB >> 7628579

The impact of W. K. Röntgen's discovery on the use of internalizable sources of ionizing energy in diagnostic and therapeutic nuclear medicine.

H Rösler.   

Abstract

The early history of cathode rays, X-rays and a third kind of natural radiation from several minerals and atomic fission is described. In this way the fundamental concept of radioactivity, laws of decay and atomic models were developed. With artificial radioactive isotopes, new tailored radiopharmaceuticals could be introduced into metabolic research, medical diagnostics and therapy. Von Hevesy's concept of the dynamic state of body constituents led to examination of the locations and movements of labelled atoms and molecules as a function of time. That was the birth of nuclear medicine. The principles and value at the molecular level of several specific tracer studies in research and diagnostic or therapeutic use are explained. Typically, diagnostic tests with tracer agents are non-invasive and have low radiation exposure. Competing with other diagnostic and therapeutic modalities, nuclear medicine is a speciality in its own right. But there are moves to classify it as a subspecialization of other organ-oriented clinical disciplines. That is a misunderstanding of the radiologist's role and does not answer the question: What is the best way of working for the patient? New horizons in diagnostic modalities, biochemistry, immunology, imaging and the use of immunogenic therapeutic agents demand a continuous cooperation within interdisciplinary teams. That is as necessary with radiologic departments, participating in changed organizational structures, as with other clinical departments.

Entities:  

Mesh:

Year:  1995        PMID: 7628579     DOI: 10.1007/bf01941266

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  36 in total

1.  A clinical study of a new renal function test: the radioactive diodrast renogram.

Authors:  C C WINTER
Journal:  J Urol       Date:  1956-08       Impact factor: 7.450

2.  Effective dose from radiopharmaceuticals.

Authors:  L Johansson; S Mattsson; B Nosslin; S Leide-Svegborn
Journal:  Eur J Nucl Med       Date:  1992

3.  Application of the effective dose equivalent to nuclear medicine patients. The MIRD Committee.

Authors:  J W Poston
Journal:  J Nucl Med       Date:  1993-04       Impact factor: 10.057

4.  The new molecular medicine.

Authors:  H N Wagner
Journal:  J Nucl Med       Date:  1993-01       Impact factor: 10.057

5.  Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment.

Authors:  J A Kinser; H Roesler; T Furrer; D Grütter; H Zimmermann
Journal:  J Nucl Med       Date:  1989-12       Impact factor: 10.057

6.  Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201.

Authors:  G M Pohost; L M Zir; R H Moore; K A McKusick; T E Guiney; G A Beller
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

7.  Radioimmunotherapy: clinical results and dosimetric considerations.

Authors:  V K Langmuir
Journal:  Int J Rad Appl Instrum B       Date:  1992-02

8.  The bedside determination of extravascular lung water: a non-invasive double indicator technique using 123I-antipyrine, 113mIn-transferrin and external counting.

Authors:  R O Binswanger; H Rösler; U Noelpp; L Matter; M Haertel
Journal:  Eur J Nucl Med       Date:  1978-04-01

Review 9.  [Required dose of imaging systems--nuclear medicine].

Authors:  E Moser; O Schober
Journal:  Radiologe       Date:  1994-04       Impact factor: 0.635

Review 10.  Radioimmunology. Imaging and therapy.

Authors:  S M Larson
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

View more
  1 in total

Review 1.  Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science.

Authors:  Michael A Malfatti; Bruce A Buchholz; Heather A Enright; Benjamin J Stewart; Ted J Ognibene; A Daniel McCartt; Gabriela G Loots; Maike Zimmermann; Tiffany M Scharadin; George D Cimino; Brian A Jonas; Chong-Xian Pan; Graham Bench; Paul T Henderson; Kenneth W Turteltaub
Journal:  Toxics       Date:  2019-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.